Payment overview · 2025
General Payments
$1,351.68
10 reported records · 1 companies
Healthcare provider profile · identity verified
Desiree Chow, MD
Allopathic & Osteopathic Physicians|Internal Medicine · NEW YORK, NY · NPI 1043410897
Verified facts
What the public records show
CMS Open Payments records show Desiree Chow, MD received $1,351.68 in general payments during 2025 across 10 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $1,351.68 | 100.0% | 10 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,351.68 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LUX-Dx Insertable Cardiac Monitor Normalized: lux dx insertable cardiac monitor |
Device | Boston Scientific Corporation | $652.82 | 4 | 2025 |
Source payment records
|
|||||
| EMBLEM MRI S-ICD Normalized: emblem mri s icd |
Device | Boston Scientific Corporation | $356.97 | 3 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $341.89 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 981 | 373 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 494 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 363 | 139 |
| Lisinopril | Lisinopril | 327 | 135 |
| Gabapentin | Gabapentin | 309 | 105 |
| Omeprazole | Omeprazole | 305 | 97 |
| Metformin Hcl | Metformin Hcl | 300 | 116 |
| Levothyroxine Sodium | Levothyroxine Sodium | 297 | 93 |
| Fluticasone Propionate | Fluticasone Propionate | 272 | 89 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 270 | 100 |
| Losartan Potassium | Losartan Potassium | 193 | 78 |
| Nifedipine Er | Nifedipine | 190 | 75 |
| Jardiance | Empagliflozin | 187 | 65 |
| Diclofenac Sodium | Diclofenac Sodium | 185 | 67 |
| Famotidine | Famotidine | 184 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 179 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 165 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 154 | 67 |
| Trazodone Hcl | Trazodone Hcl | 131 | 37 |
| Metformin Hcl Er | Metformin Hcl | 130 | 44 |
| Montelukast Sodium | Montelukast Sodium | 130 | 47 |
| Alendronate Sodium | Alendronate Sodium | 121 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 113 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 110 | 39 |
| Meloxicam | Meloxicam | 109 | 31 |
| Sertraline Hcl | Sertraline Hcl | 109 | 22 |
| Ozempic | Semaglutide | 107 | 32 |
| Tramadol Hcl | Tramadol Hcl | 107 | 20 |
| Januvia | Sitagliptin Phosphate | 102 | 34 |
| Eliquis | Apixaban | 98 | 27 |
| Rybelsus | Semaglutide | 92 | 29 |
| Breo Ellipta | Fluticasone/Vilanterol | 90 | 23 |
| Pregabalin | Pregabalin | 81 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 75 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 74 | 29 |
| Carvedilol | Carvedilol | 73 | 32 |
| Mirtazapine | Mirtazapine | 73 | 23 |
| Simvastatin | Simvastatin | 72 | 27 |
| Mounjaro | Tirzepatide | 70 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 70 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 70 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 65 | 19 |
| Ezetimibe | Ezetimibe | 65 | 27 |
| Azelastine Hcl | Azelastine Hcl | 61 | 14 |
| Valsartan | Valsartan | 61 | 25 |
| Ibuprofen | Ibuprofen | 60 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 59 | 19 |
| Ipratropium Bromide | Ipratropium Bromide | 59 | 16 |
| Irbesartan | Irbesartan | 57 | 19 |
| Meclizine Hcl | Meclizine Hcl | 56 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 16 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 54 | 18 |
| Furosemide | Furosemide | 54 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 51 | 15 |
| Enalapril Maleate | Enalapril Maleate | 50 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 49 | 15 |
| Valacyclovir | Valacyclovir Hcl | 49 | 14 |
| Naproxen | Naproxen | 48 | 19 |
| Prednisone | Prednisone | 48 | 21 |
| Spironolactone | Spironolactone | 48 | 19 |
| Topiramate | Topiramate | 48 | suppressed |
| Allopurinol | Allopurinol | 47 | 14 |
| Ammonium Lactate | Ammonium Lactate | 47 | 19 |
| Farxiga | Dapagliflozin Propanediol | 47 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 47 | 20 |
| Linzess | Linaclotide | 46 | 13 |
| Xarelto | Rivaroxaban | 46 | 15 |
| Labetalol Hcl | Labetalol Hcl | 43 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 11 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 40 | suppressed |
| Chlorthalidone | Chlorthalidone | 39 | 18 |
| Clotrimazole | Clotrimazole | 39 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 39 | 12 |
| Trulicity | Dulaglutide | 39 | 14 |
| Ketoconazole | Ketoconazole | 38 | 16 |
| Mupirocin | Mupirocin | 38 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 38 | suppressed |
| Ramipril | Ramipril | 38 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 36 | 13 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 35 | suppressed |
| Finasteride | Finasteride | 35 | 14 |
| Alprazolam | Alprazolam | 34 | suppressed |
| Bumetanide | Bumetanide | 34 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 33 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 32 | suppressed |
| Atenolol | Atenolol | 31 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 30 | suppressed |
| Fentanyl | Fentanyl | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | 15 |
| Nexium | Esomeprazole Magnesium | 29 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 29 | 13 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 27 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 26 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Baclofen | Baclofen | 25 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 25 | suppressed |
| Diazepam | Diazepam | 25 | 13 |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | 13 |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Estradiol | Estradiol | 23 | 11 |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Repaglinide | Repaglinide | 22 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 22 | 13 |
| Glipizide Er | Glipizide | 21 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 19 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 19 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Colchicine | Colchicine | 18 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Ursodiol | Ursodiol | 16 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 14 | suppressed |
| Azithromycin | Azithromycin | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Potassium Chloride | Potassium Chloride | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 13 |
| Tradjenta | Linagliptin | 13 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Percocet | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,351.68 · 10 records | Boston Scientific Corporation | EMBLEM MRI S-ICD, General - Therapies, LUX-Dx Insertable Cardiac Monitor | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error